A Dose-ranging Phase I/II Study of STI571 in Combination With Cytarabin in Patients With First Chronic Phase Chronic Myeloid Leukemia.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 19 Jul 2013
At a glance
- Drugs Imatinib (Primary) ; Cytarabine
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 19 Jul 2013 Results published in the European Journal of Cancer.
- 02 Sep 2005 New trial record.